Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.
about
A series of Fas receptor agonist antibodies that demonstrate an inverse correlation between affinity and potencyBeyond natural antibodies: the power of in vitro display technologies.Monoclonal antibody targeting of fibroblast growth factor receptor 1c ameliorates obesity and glucose intolerance via central mechanisms.Isolation, identification and expression of specific human CD133 antibodies.Phage display and hybridoma generation of antibodies to human CXCR2 yields antibodies with distinct mechanisms and epitopes.Isolation of Potent CGRP Neutralizing Antibodies Using Four Simple Assays.A Shorter Route to Antibody Binders via Quantitative in vitro Bead-Display Screening and Consensus Analysis.Death receptors as targets in cancerFeasibility of implementing cell-based pathway reporter assays in early high-throughput screening assay cascades for antibody drug discovery.Versatility of homogeneous time-resolved fluorescence resonance energy transfer assays for biologics drug discovery.Structure and characterization of a high affinity C5a monoclonal antibody that blocks binding to C5aR1 and C5aR2 receptors.Isolation of blood-brain barrier-crossing antibodies from a phage display library by competitive elution and their ability to penetrate the central nervous system.
P2860
Q27676800-E0E30717-A96D-4E6A-8822-ECF7DD0D666EQ33841864-0B199C51-F625-4B71-AC3B-DF9BF8100985Q34575896-D2842D0C-03BA-4F5A-A1CC-A8F3AD9F6CF8Q35052038-CFE22A24-FB3B-44A9-98F3-ACB5B2BC8881Q35498810-B7297CFC-EAE8-4FAB-ACEE-AE631C105FBEQ35801031-1CE7F7E0-5306-4E98-AC2D-F1BC7954D7C8Q36183984-9061DC4A-BE08-4B58-A922-3F444679DEB1Q38103591-3EE2D251-BE06-4E90-8633-1E53D5F0BD03Q39365706-6157635C-A49A-4346-9982-B91A20A2E846Q46816575-A39C8C3A-61A9-4ACA-A52F-45A935FC6899Q50277552-84E2F8F5-9429-4401-A623-0F674BAC42D0Q55265198-486E9AF1-9C9C-4B8F-80A8-A74DB9CB1F09
P2860
Human monomeric antibody fragments to TRAIL-R1 and TRAIL-R2 that display potent in vitro agonism.
description
2009 nî lūn-bûn
@nan
2009 թուականի Նոյեմբերին հրատարակուած գիտական յօդուած
@hyw
2009 թվականի նոյեմբերին հրատարակված գիտական հոդված
@hy
2009年の論文
@ja
2009年論文
@yue
2009年論文
@zh-hant
2009年論文
@zh-hk
2009年論文
@zh-mo
2009年論文
@zh-tw
2009年论文
@wuu
name
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@ast
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@en
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@nl
type
label
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@ast
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@en
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@nl
prefLabel
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@ast
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@en
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@nl
P2093
P2860
P356
P1476
Human monomeric antibody fragm ...... splay potent in vitro agonism.
@en
P2093
Bryan M Edwards
Claire L Dobson
Karen Cadwallader
Matthieu Chodorge
Philip Newton
Ralph R Minter
Robin Humphreys
Sarah Main
Tristan J Vaughan
Vivian Albert
P2860
P304
P356
10.4161/MABS.1.6.10057
P577
2009-11-11T00:00:00Z